Corvus Pharmaceuticals (CRVS) Change in Account Payables: 2022-2025
Historic Change in Account Payables for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Sep 2025 value amounting to -$1.2 million.
- Corvus Pharmaceuticals' Change in Account Payables fell 276.21% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101,000, marking a year-over-year decrease of 78.46%. This contributed to the annual value of $1.1 million for FY2024, which is 334.37% up from last year.
- Latest data reveals that Corvus Pharmaceuticals reported Change in Account Payables of -$1.2 million as of Q3 2025, which was down 163.59% from $1.8 million recorded in Q2 2025.
- In the past 5 years, Corvus Pharmaceuticals' Change in Account Payables registered a high of $1.8 million during Q2 2025, and its lowest value of -$2.3 million during Q4 2022.
- Moreover, its 3-year median value for Change in Account Payables was $84,000 (2024), whereas its average is -$181.82.
- Data for Corvus Pharmaceuticals' Change in Account Payables shows a peak YoY increase of 561.87% (in 2025) and a maximum YoY decrease of 1,616.67% (in 2025) over the last 5 years.
- Quarterly analysis of 4 years shows Corvus Pharmaceuticals' Change in Account Payables stood at -$2.3 million in 2022, then surged by 105.38% to $121,000 in 2023, then spiked by 485.95% to $709,000 in 2024, then slumped by 276.21% to -$1.2 million in 2025.
- Its Change in Account Payables was -$1.2 million in Q3 2025, compared to $1.8 million in Q2 2025 and -$1.3 million in Q1 2025.